U.S. flag

An official website of the United States government

NM_006019.4(TCIRG1):c.1549G>A (p.Asp517Asn) AND Osteopetrosis

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Jul 23, 2020
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001251405.9

Allele description [Variation Report for NM_006019.4(TCIRG1):c.1549G>A (p.Asp517Asn)]

NM_006019.4(TCIRG1):c.1549G>A (p.Asp517Asn)

Gene:
TCIRG1:T cell immune regulator 1, ATPase H+ transporting V0 subunit a3 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11q13.2
Genomic location:
Preferred name:
NM_006019.4(TCIRG1):c.1549G>A (p.Asp517Asn)
HGVS:
  • NC_000011.10:g.68047967G>A
  • NG_007878.1:g.13952G>A
  • NM_001351059.2:c.655G>A
  • NM_006019.4:c.1549G>AMANE SELECT
  • NM_006053.4:c.901G>A
  • NP_001337988.1:p.Asp219Asn
  • NP_006010.2:p.Asp517Asn
  • NP_006044.1:p.Asp301Asn
  • LRG_115:g.13952G>A
  • NC_000011.9:g.67815434G>A
  • NM_006019.3:c.1549G>A
  • p.Asp517Asn
Protein change:
D219N
Links:
dbSNP: rs369264588
NCBI 1000 Genomes Browser:
rs369264588
Molecular consequence:
  • NM_001351059.2:c.655G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_006019.4:c.1549G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_006053.4:c.901G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Osteopetrosis
Identifiers:
MONDO: MONDO:0017198; MedGen: C0029454; Human Phenotype Ontology: HP:0011002

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001426994Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Likely pathogenic
(Jul 23, 2020)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

TCIRG1-dependent recessive osteopetrosis: mutation analysis, functional identification of the splicing defects, and in vitro rescue by U1 snRNA.

Susani L, Pangrazio A, Sobacchi C, Taranta A, Mortier G, Savarirayan R, Villa A, Orchard P, Vezzoni P, Albertini A, Frattini A, Pagani F.

Hum Mutat. 2004 Sep;24(3):225-35.

PubMed [citation]
PMID:
15300850

TCIRG1 Transgenic Rescue of Osteoclast Function Using Induced Pluripotent Stem Cells Derived from Patients with Infantile Malignant Autosomal Recessive Osteopetrosis.

Chen W, Twaroski K, Eide C, Riddle MJ, Orchard PJ, Tolar J.

J Bone Joint Surg Am. 2019 Nov 6;101(21):1939-1947. doi: 10.2106/JBJS.19.00558.

PubMed [citation]
PMID:
31567691
See all PubMed Citations (3)

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV001426994.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

Variant summary: TCIRG1 c.1549G>A (p.Asp517Asn) results in a conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 2.8e-05 in 250564 control chromosomes. c.1549G>A has been reported in the literature in individuals affected with Osteopetrosis (e.g. Susani_2004, Chen_2019). These data indicate that the variant may be associated with disease. At least one publication reports in vitro experimental evidence that osteoclasts derived from patient cells with this and another pathogenic variant in compound heterozygosity were impaired but functionality could be rescued by transgenic expression of TCIRG1 (Chen_2019). However, the individual contributions of these mutations to this phenotype were not assesed. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 3, 2024